skip to Main Content
Bonjour, | Log in
  • Français


Be part of the predictive
medicine revolution

Predilife announces the great success of its capital increase to finance its growth.

« I would like to thank all the subscribers for their interest in this project and the confidence they have shown in us. The success of this capital increase provides us with increased financial resources to accelerate the commercial deployment of the Mammorisk® solution in Europe. »

Stéphane Ragusa – Chairman and CEO

Access to the press release announcing the success of the capital increase.

For any
information request

Back To Top